169 related articles for article (PubMed ID: 16143522)
1. Bicyclic heteroarylpiperazines as selective brain penetrant 5-HT6 receptor antagonists.
Ahmed M; Briggs MA; Bromidge SM; Buck T; Campbell L; Deeks NJ; Garner A; Gordon L; Hamprecht DW; Holland V; Johnson CN; Medhurst AD; Mitchell DJ; Moss SF; Powles J; Seal JT; Stean TO; Stemp G; Thompson M; Trail B; Upton N; Winborn K; Witty DR
Bioorg Med Chem Lett; 2005 Nov; 15(21):4867-71. PubMed ID: 16143522
[TBL] [Abstract][Full Text] [Related]
2. Tricyclic azepine derivatives as selective brain penetrant 5-HT6 receptor antagonists.
Trani G; Baddeley SM; Briggs MA; Chuang TT; Deeks NJ; Johnson CN; Khazragi AA; Mead TL; Medhurst AD; Milner PH; Quinn LP; Ray AM; Rivers DA; Stean TO; Stemp G; Trail BK; Witty DR
Bioorg Med Chem Lett; 2008 Oct; 18(20):5698-700. PubMed ID: 18793848
[TBL] [Abstract][Full Text] [Related]
3. Bicyclic piperazinylbenzenesulphonamides are potent and selective 5-HT6 receptor antagonists.
Bromidge SM; Clarke SE; King FD; Lovell PJ; Newman H; Riley G; Routledge C; Serafinowska HT; Smith DR; Thomas DR
Bioorg Med Chem Lett; 2002 May; 12(10):1357-60. PubMed ID: 11992776
[TBL] [Abstract][Full Text] [Related]
4. 5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonists.
Liu KG; Robichaud AJ; Bernotas RC; Yan Y; Lo JR; Zhang MY; Hughes ZA; Huselton C; Zhang GM; Zhang JY; Kowal DM; Smith DL; Schechter LE; Comery TA
J Med Chem; 2010 Nov; 53(21):7639-46. PubMed ID: 20932009
[TBL] [Abstract][Full Text] [Related]
5. Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134).
Bromidge SM; Clarke SE; Gager T; Griffith K; Jeffrey P; Jennings AJ; Joiner GF; King FD; Lovell PJ; Moss SF; Newman H; Riley G; Rogers D; Routledge C; Serafinowska H; Smith DR
Bioorg Med Chem Lett; 2001 Jan; 11(1):55-8. PubMed ID: 11140733
[TBL] [Abstract][Full Text] [Related]
6. Influence of the 5-HT6 receptor on acetylcholine release in the cortex: pharmacological characterization of 4-(2-bromo-6-pyrrolidin-1-ylpyridine-4-sulfonyl)phenylamine, a potent and selective 5-HT6 receptor antagonist.
Riemer C; Borroni E; Levet-Trafit B; Martin JR; Poli S; Porter RH; Bös M
J Med Chem; 2003 Mar; 46(7):1273-6. PubMed ID: 12646038
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of potent and orally active 5-HT4 receptor antagonists: indazole and benzimidazolone derivatives.
Schaus JM; Thompson DC; Bloomquist WE; Susemichel AD; Calligaro DO; Cohen ML
J Med Chem; 1998 May; 41(11):1943-55. PubMed ID: 9599243
[TBL] [Abstract][Full Text] [Related]
8. 8-Piperazinyl-2,3-dihydropyrrolo[3,2-g]isoquinolines: potent, selective, orally bioavailable 5-HT1 receptor ligands.
Heightman TD; Gaster LM; Pardoe SL; Pilleux JP; Hadley MS; Middlemiss DN; Price GW; Roberts C; Scott CM; Watson JM; Gordon LJ; Holland VA; Powles J; Riley GJ; Stean TO; Trail BK; Upton N; Austin NE; Ayrton AD; Coleman T; Cutler L
Bioorg Med Chem Lett; 2005 Oct; 15(19):4370-4. PubMed ID: 16039851
[TBL] [Abstract][Full Text] [Related]
9. 3,4-Dihydro-2H-benzo[1,4]oxazine derivatives as 5-HT6 receptor antagonists.
Zhao SH; Berger J; Clark RD; Sethofer SG; Krauss NE; Brothers JM; Martin RS; Misner DL; Schwab D; Alexandrova L
Bioorg Med Chem Lett; 2007 Jun; 17(12):3504-7. PubMed ID: 17485206
[TBL] [Abstract][Full Text] [Related]
10. 6-Chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]- indoline (SB-242084): the first selective and brain penetrant 5-HT2C receptor antagonist.
Bromidge SM; Duckworth M; Forbes IT; Ham P; King FD; Thewlis KM; Blaney FE; Naylor CB; Blackburn TP; Kennett GA; Wood MD; Clarke SE
J Med Chem; 1997 Oct; 40(22):3494-6. PubMed ID: 9357513
[No Abstract] [Full Text] [Related]
11. Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists.
Cole DC; Lennox WJ; Stock JR; Ellingboe JW; Mazandarani H; Smith DL; Zhang G; Tawa GJ; Schechter LE
Bioorg Med Chem Lett; 2005 Nov; 15(21):4780-5. PubMed ID: 16125933
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationship studies of CNS agents. Part 14: Structural requirements for the 5-HT1A and 5-HT2A receptor selectivity of simple 1-(2-pyrimidinyl)piperazine derivatives.
Mokrosz JL; Strekowski L; Duszyńska B; Harden DB; Mokrosz MJ; Bojarski AJ
Pharmazie; 1994 Nov; 49(11):801-6. PubMed ID: 7838864
[TBL] [Abstract][Full Text] [Related]
13. Modification of the structure of 4, 6-disubstituted 2-(4-alkyl-1-piperazinyl)pyridines: synthesis and their 5-HT2A receptor activity.
Paluchowska MH; Bojarski AJ; Bugno R; Charakchieva-Minol S; Wesołowska A
Arch Pharm (Weinheim); 2003 Apr; 336(2):104-10. PubMed ID: 12761763
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and pharmacological evaluation of piperidin-4-yl amino aryl sulfonamides: novel, potent, selective, orally active, and brain penetrant 5-HT₆ receptor antagonists.
Nirogi R; Shinde A; Daulatabad A; Kambhampati R; Gudla P; Shaik M; Gampa M; Balasubramaniam S; Gangadasari P; Reballi V; Badange R; Bojja K; Subramanian R; Bhyrapuneni G; Muddana N; Jayarajan P
J Med Chem; 2012 Nov; 55(21):9255-69. PubMed ID: 23006002
[TBL] [Abstract][Full Text] [Related]
15. Lack of localization of 5-HT6 receptors on cholinergic neurons: implication of multiple neurotransmitter systems in 5-HT6 receptor-mediated acetylcholine release.
Marcos B; Gil-Bea FJ; Hirst WD; García-Alloza M; Ramírez MJ
Eur J Neurosci; 2006 Sep; 24(5):1299-306. PubMed ID: 16987217
[TBL] [Abstract][Full Text] [Related]
16. 2,5-diketopiperazines as potent, selective, and orally bioavailable oxytocin antagonists. 2. Synthesis, chirality, and pharmacokinetics.
Borthwick AD; Davies DE; Exall AM; Livermore DG; Sollis SL; Nerozzi F; Allen MJ; Perren M; Shabbir SS; Woollard PM; Wyatt PG
J Med Chem; 2005 Nov; 48(22):6956-69. PubMed ID: 16250654
[TBL] [Abstract][Full Text] [Related]
17. Oral administration of the 5-HT6 receptor antagonists SB-357134 and SB-399885 improves memory formation in an autoshaping learning task.
Perez-García G; Meneses A
Pharmacol Biochem Behav; 2005 Jul; 81(3):673-82. PubMed ID: 15964617
[TBL] [Abstract][Full Text] [Related]
18. Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats.
Wesołowska A; Nikiforuk A; Stachowicz K
Behav Pharmacol; 2007 Sep; 18(5-6):439-46. PubMed ID: 17762512
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and in vivo evaluation of phenethylpiperazine amides: selective 5-hydroxytryptamine(2A) receptor antagonists for the treatment of insomnia.
Xiong Y; Ullman B; Choi JS; Cherrier M; Strah-Pleynet S; Decaire M; Dosa PI; Feichtinger K; Teegarden BR; Frazer JM; Yoon WH; Shan Y; Whelan K; Hauser EK; Grottick AJ; Semple G; Al-Shamma H
J Med Chem; 2010 Aug; 53(15):5696-706. PubMed ID: 20684606
[TBL] [Abstract][Full Text] [Related]
20. 5-Cyclic amine-3-arylsulfonylindazoles as novel 5-HT6 receptor antagonists.
Haydar SN; Yun H; Andrae PM; Mattes J; Zhang J; Kramer A; Smith DL; Huselton C; Graf R; Aschmies S; Schechter LE; Comery TA; Robichaud AJ
J Med Chem; 2010 Mar; 53(6):2521-7. PubMed ID: 20170099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
